Lorrin Yee

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study

Irene Braña, Antonio Calles, Patricia LoRusso et al. · Targeted Oncology · 2014 · 210 citations

Medicine, Oncology, Pharmacology +15

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas

Monica Mita, Matthew A. Spear, Lorrin Yee et al. · Clinical Cancer Research · 2010 · 107 citations

Medicine, Oncology, Pharmacology +16

A Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia in Patients With Breast, Lung, or Gynecologic Cancer

Lee S. Schwartzberg, Lorrin Yee, Frank M. Senecal et al. · The Oncologist · 2004 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors

Patricia LoRusso, Pasi A. Jänne, Moacyr Oliveira et al. · Clinical Cancer Research · 2013 · 91 citations

Medicine, Oncology, Pharmacology +17

A Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid Tumors

Peter J. Rosen, Christopher J. Sweeney, Dorothy J. Park et al. · Clinical Cancer Research · 2010 · 69 citations

Pharmacy, Oncology, Pharmacology +16